122 related articles for article (PubMed ID: 10431690)
41. Induction of tumor-specific cytotoxicity in tumor infiltrating lymphocytes by HPV16 and HPV18 E7-pulsed autologous dendritic cells in patients with cancer of the uterine cervix.
Santin AD; Bellone S; Palmieri M; Bossini B; Roman JJ; Cannon MJ; Bignotti E; Canè S; Pecorelli S
Gynecol Oncol; 2003 May; 89(2):271-80. PubMed ID: 12713991
[TBL] [Abstract][Full Text] [Related]
42. Study of tumor-infiltrating lymphocytes for adoptive therapy of renal cell carcinoma (RCC) and metastatic melanoma: sequential proliferation of cytotoxic natural killer and noncytotoxic T cells in RCC.
Hayakawa K; Salmeron MA; Parkinson DR; Markowitz AB; von Eschenbach AC; Legha SS; Balch CM; Ross MI; Augustus LB; Itoh K
J Immunother (1991); 1991 Oct; 10(5):313-25. PubMed ID: 1790139
[TBL] [Abstract][Full Text] [Related]
43. Immune inhibitory effects of renal cell carcinoma extract on lectin and alloantigen-induced peripheral blood and tumor infiltrating lymphocyte blastogenesis.
Shabtai M; Ye H; Kono K; Takayam T; Terashima K; Tsukuda K; Frischer Z; Waltzer WC; Malinowski K
Urol Oncol; 2003; 21(1):27-32. PubMed ID: 12684124
[TBL] [Abstract][Full Text] [Related]
44. Quantitative analysis of Th1, Th2 and TGF-beta1 cytokine expression in tumor, TIL and PBL of non-small cell lung cancer patients.
Asselin-Paturel C; Echchakir H; Carayol G; Gay F; Opolon P; Grunenwald D; Chouaib S; Mami-Chouaib F
Int J Cancer; 1998 Jul; 77(1):7-12. PubMed ID: 9639386
[TBL] [Abstract][Full Text] [Related]
45. Clonal analysis of tumor-infiltrating lymphocytes from human primary and metastatic liver tumors.
Shimizu Y; Iwatsuki S; Herberman RB; Whiteside TL
Int J Cancer; 1990 Nov; 46(5):878-83. PubMed ID: 2146230
[TBL] [Abstract][Full Text] [Related]
46. Defective lymphokine production by most CD8+ and CD4+ tumor-specific T cell clones derived from human melanoma-infiltrating lymphocytes in response to autologous tumor cells in vitro.
Guilloux Y; Viret C; Gervois N; Le Dréan E; Pandolfino MC; Diez E; Jotereau F
Eur J Immunol; 1994 Sep; 24(9):1966-73. PubMed ID: 7522155
[TBL] [Abstract][Full Text] [Related]
47. Presentation of renal tumor antigens by human dendritic cells activates tumor-infiltrating lymphocytes against autologous tumor: implications for live kidney cancer vaccines.
Mulders P; Tso CL; Gitlitz B; Kaboo R; Hinkel A; Frand S; Kiertscher S; Roth MD; deKernion J; Figlin R; Belldegrun A
Clin Cancer Res; 1999 Feb; 5(2):445-54. PubMed ID: 10037196
[TBL] [Abstract][Full Text] [Related]
48. Characterization of fresh (uncultured) tumour-infiltrating lymphocytes (TIL) and TIL-derived T cell lines from patients with renal cell carcinoma.
Mitropoulos D; Kooi S; Rodriguez-Villanueva J; Platsoucas CD
Clin Exp Immunol; 1994 Aug; 97(2):321-7. PubMed ID: 8050183
[TBL] [Abstract][Full Text] [Related]
49. Expression of cytokine mRNA transcripts in renal cell carcinoma.
Olive C; Cheung C; Nicol D; Falk MC
Immunol Cell Biol; 1998 Aug; 76(4):357-62. PubMed ID: 9723777
[TBL] [Abstract][Full Text] [Related]
50. MHC class-I-restricted auto-tumor-specific CD4+CD8- T-cell clones established from autologous mixed lymphocyte-tumor-cell culture (MLTC).
Wang P; Vánky F; Klein E
Int J Cancer; 1992 Jul; 51(6):962-7. PubMed ID: 1386348
[TBL] [Abstract][Full Text] [Related]
51. Lymphokine production by human melanoma tumor-infiltrating lymphocytes.
Salmeron MA; Morita T; Seki H; Platsoucas CD; Itoh K
Cancer Immunol Immunother; 1992; 35(3):211-7. PubMed ID: 1386286
[TBL] [Abstract][Full Text] [Related]
52. Suppression of lymphokine-activated killer cell generation by tumor-infiltrating lymphocytes.
Chakraborty NG; Sporn JR; Pasquale DR; Ergin MT; Mukherji B
Clin Immunol Immunopathol; 1991 Jun; 59(3):407-16. PubMed ID: 2029793
[TBL] [Abstract][Full Text] [Related]
53. Restoration of tumor specific human leukocyte antigens class I-restricted cytotoxicity by dendritic cell stimulation of tumor infiltrating lymphocytes in patients with advanced ovarian cancer.
Santin AD; Bellone S; Palmieri M; Bossini B; Cane' S; Bignotti E; Roman JJ; Cannon MJ; Pecorelli S
Int J Gynecol Cancer; 2004; 14(1):64-75. PubMed ID: 14764031
[TBL] [Abstract][Full Text] [Related]
54. Recombinant interleukin-2-expanded tumor infiltrating lymphocytes from human renal cell cancer do not exhibit autologous tumor cell-specific cytotoxicity.
Nishimura T; Terashima Y; Hattori T; Satoh M; Kondo Y; Kimura G; Yoshida K; Akimoto M
Urol Int; 1991; 47 Suppl 1():83-5. PubMed ID: 1949387
[TBL] [Abstract][Full Text] [Related]
55. Characterization of a human renal cell carcinoma specific cytotoxic CD8+ T cell line.
Finke JH; Rayman P; Edinger M; Tubbs RR; Stanley J; Klein E; Bukowski R
J Immunother (1991); 1992 Jan; 11(1):1-11. PubMed ID: 1734943
[TBL] [Abstract][Full Text] [Related]
56. Renal Cell Carcinoma-Infiltrating CD3
Lee HW; Park C; Joung JG; Kang M; Chung YS; Oh WJ; Yeom SY; Park WY; Kim TJ; Seo SI
Curr Issues Mol Biol; 2021 May; 43(1):226-239. PubMed ID: 34071865
[TBL] [Abstract][Full Text] [Related]
57. Defective granzyme B gene expression and lytic response in T lymphocytes infiltrating human renal cell carcinoma.
Kudoh S; Redovan C; Rayman P; Edinger M; Tubbs RR; Novick A; Finke JH; Bukowski RM
J Immunother; 1997 Nov; 20(6):479-87. PubMed ID: 9409454
[TBL] [Abstract][Full Text] [Related]
58. Cellular characteristics of peripheral blood lymphocytes and tumour-infiltrating lymphocytes in patients with gynaecological tumours.
Schöndorf T; Engel H; Lindemann C; Kolhagen H; von Rücker AA; Mallmann P
Cancer Immunol Immunother; 1997 Apr; 44(2):88-96. PubMed ID: 9177470
[TBL] [Abstract][Full Text] [Related]
59. T cell functions of IL-2-activated tumor-infiltrating lymphocytes from renal cell carcinoma.
Morita T; Salmeron MA; Hayakawa K; Swanson DA; von Eschenbach AC; Itoh K
Reg Immunol; 1992; 4(4):225-35. PubMed ID: 1476875
[TBL] [Abstract][Full Text] [Related]
60. CD4+ T cell clones isolated from human renal cell carcinoma possess the functional characteristics of Th2 helper cells.
Schoof DD; Terashima Y; Peoples GE; Goedegebuure PS; Andrews JV; Richie JP; Eberlein TJ
Cell Immunol; 1993 Aug; 150(1):114-23. PubMed ID: 8102084
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]